Perigon Wealth Management’s Lantern Pharma LTRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-39,387	Closed	-$139K	–	1085
2025 Q1	$139K	Buy	39,387 +24,787	+170%	+$87.7K	﹤0.01%	994
2024 Q4	$52.6K	Sell	14,600 -14,300	-49%	-$51.5K	﹤0.01%	1032
2024 Q3	$106K	Buy	+28,900	New	+$106K	﹤0.01%	964